3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Breast Neoplasms
299
Carcinoma, Non-Small-Cell Lung
224
Neoplasms
192
Prostatic Neoplasms
163
Multiple Myeloma
139
Neoplasm Metastasis
117
Melanoma
112
Colorectal Neoplasms
107
Leukemia, Myeloid, Acute
105
Lung Neoplasms
98
Lymphoma
96
Ovarian Neoplasms
84
Squamous Cell Carcinoma of Head and Neck
77
Lymphoma, Non-Hodgkin
73
Leukemia, Lymphocytic, Chronic, B-Cell
72
Triple Negative Breast Neoplasms
64
Pancreatic Neoplasms
64
Myelodysplastic Syndromes
64
Hematologic Neoplasms
60
Parkinson Disease 4, Autosomal Dominant Lewy Body
59
Head and Neck Neoplasms
59
Glioblastoma
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Recurrence
56
Leukemia
55
Sarcoma
50
Brain Neoplasms
49
Lymphoma, Large B-Cell, Diffuse
48
Carcinoma, Hepatocellular
47
Lymphoma, Follicular
46
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Nerve Tissue
×
1 year
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts